Login to make your Collection, Create Playlists and Favourite Songs

Login / Register
The Devil in the Details -- Chapter Five
The Devil in the Details -- Chapter Five

The Devil in the Details -- Chapter Five

00:00:36
Report
It’s September 2024 and a group of American thalidomide survivors arrive in Washington D.C. to lobby the government for support. More than 60 years have gone by since Frances Kelsey first stalled the New Drug Approval application from pharma company Merrell for thalidomide. Although she stopped the drug from going on the market in the U.S., hundreds of pregnant women still took thalidomide in Merrell’s so-called clinical trials, and many had babies with shortened limbs and serious medical conditions. Others had miscarriages or stillborn babies. Here we look at the legacy of thalidomide, the changes in drug regulations in the wake of the scandal, and what happened to our hero, Frances Kelsey. 

The Devil in the Details -- Chapter Five

View more comments
View All Notifications